481 results on '"Assi, Tarek"'
Search Results
2. Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review
3. Paths to improve voluntary blood donation in mixed public/private blood donation systems such as in Lebanon?
4. UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?
5. Desmoid-type fibromatosis: Current therapeutic strategies and future perspectives
6. How to improve issuing, transfusion and follow-up of blood components in Southern and Eastern Mediterranean countries? A benchmark assessment
7. Sarcoma of unknown primary: myth or reality?
8. The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry
9. Immune checkpoint inhibitors in follicular dendritic cell sarcoma
10. Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy
11. Chemotherapy in the management of periosteal osteosarcoma: A narrative review
12. Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review
13. A comprehensive review on the diagnosis and management of intimal sarcoma of the pulmonary artery
14. Desmoid-type fibromatosis: Current Therapeutic Strategies and Future Perspectives
15. Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?
16. Long-term extracranial metastatic relapse of an intraventricular solitary fibrous tumor: a case report
17. Paraneoplastic syndromes in cancers of unknown primary: An unknown field for oncologists
18. Ipilimumab and nivolumab: the ‘new kid on the block’ in advanced angiosarcoma
19. Trabectedin and radiotherapy in soft tissue sarcomas: friends or foes?
20. Overview of the role of liquid biopsy in cancer management
21. A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin
22. Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025
23. Factors associated with the time to first palliative care consultation in Lebanese cancer patients
24. The Therapeutic use of human albumin in cancer patients’ management
25. Could the re-emerging practice of wild boar hunting linked to the recent economic crisis lead to new outbreaks of trichinellosis in Lebanon?
26. Can a decentralized blood system ensure self-sufficiency and blood safety? The Lebanese experience
27. NALIRIFOX in the upfront setting of metastatic pancreatic cancer: can FOLFIRINOX finally be dethroned?
28. Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant
29. Abridged geriatric assessment is a better predictor of overall survival than the Karnofsky Performance Scale and Physical Performance Test in elderly patients with cancer
30. Palbociclib safety and efficacy beyond Ribociclib-induced liver toxicity in metastatic hormone-receptors positive breast cancer patient
31. Overcoming the resistance to BRAF inhibitor by the double BRAF and MEK inhibitions in advanced melanoma: a case report
32. KRAS G12C mutation: from black sheep to key player in pancreatic cancer treatment
33. Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study
34. Pancreatic small cell cancer
35. Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?
36. Follicular lymphoma infiltrating the skin
37. Second-line Treatments of Advanced Hepatocellular Carcinoma: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
38. Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence
39. RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
40. Trabectedin and immune checkpoint inhibitors: a blissful combination or another failure in soft tissue sarcomas?
41. How to improve issuing, transfusion and follow-up of blood components in Southern and Eastern Mediterranean countries? A benchmark assessment
42. The role of palliative care in the last month of life in elderly cancer patients
43. Characteristics of Gastric Cancer in Lebanon: a Descriptive Study from a Single Institutional Experience
44. Targeting RET mutation in medullary thyroid cancer
45. Does a liberal national transfusion law assure blood safety? A survey of blood bank directors' perspectives in Lebanon
46. Gastrointestinal stromal tumor in North Africa and the middle east: updates in presentation and management from an 11-year retrospective cohort
47. Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer
48. Treatment of cancer patients in their last month of life: aimless chemotherapy
49. Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer
50. Radiological patterns of tumour progression in patients treated with a combination of immune checkpoint blockers and antiangiogenic drugs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.